| Bioactivity | MR2938 is a potent AChE inhibitor, with an IC50 of 5.04 μM. MR2938 also suppresses NO production obviously (IC50 = 3.29 μM). MR2938 suppresses the neuroinflammation through blocking MAPK/JNK and NF-κB signaling pathways. MR2938 can be used for Alzheimer’s disease (AD) research[1]. |
| Invitro | MR2938 (0-10 μM, 24 h) 在 1.25 μM 时降低促炎细胞因子 IL-1β、TNF-α、IL-6 和 CCL2 的 mRNA 水平[1]。MR2938 (10 μM, 24 h) 阻断 LPS 诱导的 BV-2 细胞中的 NF-κB 信号通路[1]。MR2938 (20 μM) 对 AChE 和 BChE 具有抑制活性,抑制率分别为 91.8 ± 2.68% 和 38.7 ± 11.7%[1]。MR2938 (0-10 μM) 对 BV2 细胞系的细胞活力影响很小[1]。 RT-PCR[1] Cell Line: |
| Name | MR2938 |
| CAS | 1044870-65-6 |
| Formula | C21H24N4O3 |
| Molar Mass | 380.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lv L, et al. Discovery of quinazolin-4(3H)-one derivatives as novel AChE inhibitors with anti-inflammatory activities. Eur J Med Chem. 2023 Apr 6;254:115346. |